Published :
Tables : 65
Figures : 56
Category : Healthcare
No. of Pages : 245
Report Code : HC-U3329
Plasmapheresis Market is estimated to value over USD 2.2 billion by 2027 end with a CAGR of over 8% during the forecast period 2020 to 2027. Increased incidences of autoimmune diseases, growing insistence for plasma source from biopharma companies, improving healthcare infrastructure and awareness programs in both developed and developing nations, favourable scenario for reimbursements on plasmapheresis processes and other technological advancements are some of the key driving factors responsible for the plasmapheresis market growth. Plasmapheresis or plasma exchange is a process that involves the separation and removal of plasma from the blood for eliminating an element of a disease present in the plasma. The RBCs, platelets and WBCs are returned to the patient with an additional fluid recommended by the physician. The process of plasmapheresis removes over 15 percent of plasma from the total blood volume of a patient therefore no additional plasma is required to be removed. Plasmapheresis generally involves plasma collection for manufacturing products like albumin, IVIG, factor concentrates and laboratory reagents and for transfusion. Furthermore, the increased incidences of autoimmune disorders have exponentially increased the demand for this procedure across the world. Autoimmune diseases like celiac diseases, type 1 diabetes, rheumatoid arthritis, lupus and temporal arteritis have increased the plasmapheresis market demand. As per the report published by the CDC, over 9% of the total population of the United States suffer from diabetes and over 30 million people are diagnosed with diabetes across the world. Healthcare companies are consistently improving in the development of plasmapheresis instruments like apheresis machines to provide enhancements in these instruments to conduct this process across the world. Owing to these factors the market is predicted to proliferate during the forecasted timeframe. Moreover, the plasma is required to treat different diseases like anaemia, blood loss, stomach disease, cancer which has surged the insistence for blood donations. Such factors have significantly contributed to the growth of the market. Market Segmentation: By Product Type • Disposables • Instruments By Indication • Neurological Disorders • Renal Disorders • Autoimmune Disorders • Metabolic Disorders • Hematological Disorders By Technology • Membrane Filtration • Centrifugation By Application • Therapeutic Plasmapheresis • Source Plasma Collection By End User • Hospitals and Clinics • Biopharmaceutical Industry • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into product type, indication, technology, application, end user and region. The indications segment is classified into renal disorders, neurological disorders, metabolic disorders, haematological disorders and autoimmune disorders. The autoimmune disorders is predicted to hold the largest plasmapheresis market share owing to the rise in the number of patients diagnosed with type 1 diabetes with unhealthy dietary choices. The applications the market is fragmented into source plasma collection and therapeutic plasmapheresis. The source plasma collection is anticipated to experience a substantial growth during the forecasted timeframe. The end user segment is categorised into hospitals and specialty clinics, biopharmaceutical industry and others like blood banks, therapeutic plasma collection centre and blood collection centres. Regional Analysis: The North America region is expected to dominate the market owing to improvements in the healthcare infrastructure, rising number of patients with autoimmune and neurological disorders, increased disposable income and rising adoption of plasmapheresis for treating diseases like Wegener’s Granulomatosis, thrombocytopenic purpura, etc. Competitive Landscape: Some of the prominent market players associated are Asahi Kasei Corporation, Grifols S.A., Octapharma AG, Kedrion Biopharma (KED Plasma), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Haemonetics Corporation, Terumo Corporation. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global plasmapheresis market by indication, by product type, by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increased incidences of autoimmune diseases, growing insistence for plasma source from biopharma companies, improving healthcare infrastructure and awareness programs in both developed and developing nations, favourable scenario for reimbursements on plasmapheresis processes and other technological advancements are some of the key driving factors responsible for the plasmapheresis market growth. Plasmapheresis or plasma exchange is a process that involves the separation and removal of plasma from the blood for eliminating an element of a disease present in the plasma. The RBCs, platelets and WBCs are returned to the patient with an additional fluid recommended by the physician. The process of plasmapheresis removes over 15 percent of plasma from the total blood volume of a patient therefore no additional plasma is required to be removed. Plasmapheresis generally involves plasma collection for manufacturing products like albumin, IVIG, factor concentrates and laboratory reagents and for transfusion. Furthermore, the increased incidences of autoimmune disorders have exponentially increased the demand for this procedure across the world. Autoimmune diseases like celiac diseases, type 1 diabetes, rheumatoid arthritis, lupus and temporal arteritis have increased the plasmapheresis market demand. As per the report published by the CDC, over 9% of the total population of the United States suffer from diabetes and over 30 million people are diagnosed with diabetes across the world. Healthcare companies are consistently improving in the development of plasmapheresis instruments like apheresis machines to provide enhancements in these instruments to conduct this process across the world. Owing to these factors the market is predicted to proliferate during the forecasted timeframe. Moreover, the plasma is required to treat different diseases like anaemia, blood loss, stomach disease, cancer which has surged the insistence for blood donations. Such factors have significantly contributed to the growth of the market.
Market Segmentation:
By Product Type • Disposables • Instruments By Indication • Neurological Disorders • Renal Disorders • Autoimmune Disorders • Metabolic Disorders • Hematological Disorders By Technology • Membrane Filtration • Centrifugation By Application • Therapeutic Plasmapheresis • Source Plasma Collection By End User • Hospitals and Clinics • Biopharmaceutical Industry • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into product type, indication, technology, application, end user and region. The indications segment is classified into renal disorders, neurological disorders, metabolic disorders, haematological disorders and autoimmune disorders. The autoimmune disorders is predicted to hold the largest plasmapheresis market share owing to the rise in the number of patients diagnosed with type 1 diabetes with unhealthy dietary choices. The applications the market is fragmented into source plasma collection and therapeutic plasmapheresis. The source plasma collection is anticipated to experience a substantial growth during the forecasted timeframe. The end user segment is categorised into hospitals and specialty clinics, biopharmaceutical industry and others like blood banks, therapeutic plasma collection centre and blood collection centres.
Regional Analysis:
The North America region is expected to dominate the market owing to improvements in the healthcare infrastructure, rising number of patients with autoimmune and neurological disorders, increased disposable income and rising adoption of plasmapheresis for treating diseases like Wegener’s Granulomatosis, thrombocytopenic purpura, etc.
Competitive Landscape:
Some of the prominent market players associated are Asahi Kasei Corporation, Grifols S.A., Octapharma AG, Kedrion Biopharma (KED Plasma), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Haemonetics Corporation, Terumo Corporation.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global plasmapheresis market by indication, by product type, by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Plasmapheresis Market, By Product Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Disposables 7.2 Instruments 8. Plasmapheresis Market, By Indication Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Neurological Disorders 8.2 Renal Disorders 8.3 Autoimmune Disorders 8.4 Metabolic Disorders 8.5 Hematological Disorders 9. Plasmapheresis Market, By Technology Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Membrane Filtration 9.2 Centrifugation 10. Plasmapheresis Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 10.1 Therapeutic Plasmapheresis 10.2 Source Plasma Collection 11. Plasmapheresis Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 11.1 Hospitals and Clinics 11.2 Biopharmaceutical Industry 11.3 Others 12. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1. U.S. 12.2.2. Canada 12.2.3. Mexico 12.2.4. Rest of North America 12.3 Market Size (USD Mn) Forecast for North America 2020-2027 13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5 Switzerland 14.2.6. Spain 14.2.7. Russia 14.2.8. Poland 14.2.9. Rest of Western Europe 14.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1 Introduction 15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 15.2.1 Japan 15.2.2 China 15.2.3 Singapore 15.2.4 Korea 15.2.5 India 15.2.6 Australia and New Zealand 15.2.7 ASEAN 15.2.8 Rest of Asia Pacific 15.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1 Introduction 16.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 16.2.1 UAE 16.2.2 South Africa 16.2.3 Egypt 16.2.4 Saudi Arabia 16.2.5 Rest of MEA 16.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1 Asahi Kasei Corporation 17.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2 Grifols S.A. 17.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3 Octapharma AG 17.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4 Kedrion Biopharma (KED Plasma) 17.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 B. Braun Melsungen AG 17.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 Fresenius SE & Co. KGaA 17.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7 Haemonetics Corporation 17.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8 Terumo Corporation 17.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 18. Impact of COVID-19 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. Competitive Intelligence and Competitive Matrix 19.1 Competitive Intelligence 19.2 Competitive Matrix 20. Major Deals and Strategic Alliances Analysis 20.1 Joint ventures 20.2 Mergers and acquisitions 20.3 Licensing and partnerships 20.4 Technology Collaborations 20.5 Strategic Divestments 20.6 Market Entry Strategies 21. Relevant Case Studies and Latest News Updates 22. Research Sources and List of Primary Contacts of this Study 23. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics